PHARMACEUTICAL COMPOSITION FOR ENHANCING RADIOTHERAPY COMPRISING FUSION PROTEIN CONTAINING IL-2 PROTEIN AND CD80 PROTEIN

The present invention relates to a pharmaceutical composition for enhancing radiation therapy, comprising a fusion protein dimer comprising an IL-2 protein and a CD80 protein, and a method of radiation therapy for cancer using the same. The composition for enhancing radiation therapy comprising the...

Full description

Saved in:
Bibliographic Details
Main Authors NAM, Su Youn, KOH, Young Jun, JANG, Myung Ho
Format Patent
LanguageEnglish
French
German
Published 29.11.2023
Subjects
CHEMISTRY
ELECTROTHERAPY
HUMAN NECESSITIES
HYGIENE
MAGNETOTHERAPY
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
RADIATION THERAPY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
ULTRASOUND THERAPY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a pharmaceutical composition for enhancing radiation therapy, comprising a fusion protein dimer comprising an IL-2 protein and a CD80 protein, and a method of radiation therapy for cancer using the same. The composition for enhancing radiation therapy comprising the fusion protein according to the present invention may increase the effect of radiation therapy in cancer treatment.
Bibliography:Application Number: EP20210817193